Silence Therapeutics Announces Publication in the Journal of the American Medical Association Highlighting Results From SLN360 Phase 1 Study in Healthy Adults With High Lipoprotein(a) - Press Release
– Results were simultaneously presented today in a late breaker at the American College of Cardiology's 71st Annual Scientific Session (ACC.22) in Was